Download presentation
Presentation is loading. Please wait.
Published byJemimah Randall Modified over 8 years ago
1
Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by S. Zuily, V. Regnault, C. Selton-Suty, V. Eschwège, J.-F. Bruntz, E. Bode-Dotto, E. De Maistre, P. Dotto, C. Perret-Guillaume, T. Lecompte, and D. Wahl Circulation Volume 124(2):215-224 July 12, 2011 Copyright © American Heart Association, Inc. All rights reserved.
2
Study flow diagram. S. Zuily et al. Circulation. 2011;124:215-224 Copyright © American Heart Association, Inc. All rights reserved.
3
Forest plot. S. Zuily et al. Circulation. 2011;124:215-224 Copyright © American Heart Association, Inc. All rights reserved.
4
Visual inspection of the L'Abbé plot revealed a good level of agreement without heterogeneity between studies included in the meta-analysis. S. Zuily et al. Circulation. 2011;124:215-224 Copyright © American Heart Association, Inc. All rights reserved.
5
S. Zuily et al. Circulation. 2011;124:215-224 Copyright © American Heart Association, Inc. All rights reserved.
6
S. Zuily et al. Circulation. 2011;124:215-224 Copyright © American Heart Association, Inc. All rights reserved.
7
Funnel plot of the risk of heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. S. Zuily et al. Circulation. 2011;124:215-224 Copyright © American Heart Association, Inc. All rights reserved.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.